Current News

Contact | Print version | Send article | RSS feed

Generex Biotechnology Granted Patents in Canada and Mexico
Company Expands North American Drug Delivery Platform Patent Portfolio

24 Apr 2007 - Generex Biotechnology Corporation announced that it has expanded its patent portfolio with newly issued patents in Canada and Mexico issued by the Canadian Intellectual Property Office and the Mexican Institute of Intellectual Property, respectively.
 
The Canadian patent titled "Pulmonary Drug Delivery" contains claims to an aerosol pharmaceutical formulation, metered dose dispenser, and use thereof. The patent discloses an improved delivery system for the administration of large molecule pharmaceuticals which can be administered by means of an aerosol into the mouth for buccal or pulmonary application.
 
The Mexican patent titled "Micellar Pharmaceutical Compositions for Buccal and Pulmonary Application" is an extant United States Patent held by the Company containing claims to pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form. The patent also discloses methods for making and using the pharmaceutical compositions.
 
The Company currently holds an aggregate of 84 patents worldwide (20 of which are United States Patents) and has an aggregate of 58 patent applications pending in various jurisdictions.